News & Press Releases

Medrio Completes Successful Type 2 System and Organization Controls (SOC) 2 Examination

San Francisco, CA (August 19, 2022) — Medrio, a global leader in eClinical software and services used in decentralized, hybrid, and traditional clinical trials, has successfully completed a System and Organization Controls (SOC) 2 Type 2 examination. The independent third-party report attests to the controls at Medrio regarding the security, availability, and confidentiality of its eClinical technology and solutions.
Read More »

Medrio Partners with PHARMASEAL International Ltd.

PHARMASEAL International Ltd, a technology provider of clinical trial management and governance solutions for biopharmaceutical, CROs, and medical device organizations, and leading hybrid and decentralized trials software organization, Medrio have announced that they have entered…
Read More »

Medrio, Inc. Announces Acquisition of HMD Clinical

Medrio Inc., the leading provider of eClinical technology to pharmaceutical, biotech, medical device, diagnostics, and animal health markets announced today that it has acquired HMD Clinical, a leading provider of Randomization and Trial Supply Management…
Read More »

Enter a topic, term or keyword below:

Subscribe to our mailing list

Sign up to have our the latest insights delivered to your inbox.